Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoV-2-STs in High-risk COVID-19 Patients
NCT05447013Phase 2Unknown
- Sponsor
- G. Papanikolaou General Hospital
- Start
- Jun 2021
- Primary completion
- Dec 2022
- Modality
- Adoptive Cell Transfer
- Countries
- 1
01
Overview
A Phase 2 trial of SARS-CoV-2-specific T cells in coronavirus disease 2019 (COVID-19), sponsored by G. Papanikolaou General Hospital. Status: unknown.
02
Drugs
SARS-CoV-2-specific T cells
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05447013.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05447013.